# A Study of TG103 in Subjects With Type 2 Diabetes

> **NCT04790006** · PHASE1 · UNKNOWN · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 54 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** TG103
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04790006
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04
- **Primary completion:** 2022-03
- **Final completion:** 2022-03
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2021-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790006, "A Study of TG103 in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04790006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*